Company profile ALDX
After 39 days of this quarter the interest is at 44.0. Based on that we can calculate that during remaining 52 days it will total up to 103.0. Aldeyra Therapeutics expected interest is significantly lower compared to previous quarter (-75.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 145 | 326 124.8% QoQ | 70 -78.5% QoQ | 202 188.6% QoQ |
| 2020 | 132 -9.0% YoY -34.7% QoQ | 365 12.0% YoY 176.5% QoQ | 176 151.4% YoY -51.8% QoQ | 58 -71.3% YoY -67.0% QoQ |
| 2021 | 208 57.6% YoY 258.6% QoQ | 174 -52.3% YoY -16.3% QoQ | 186 5.7% YoY 6.9% QoQ | 146 151.7% YoY -21.5% QoQ |
| 2022 | 44 -78.8% YoY -69.9% QoQ | 159 -8.6% YoY 261.4% QoQ | 122 -34.4% YoY -23.3% QoQ | 69 -52.7% YoY -43.4% QoQ |
| 2023 | 121 175.0% YoY 75.4% QoQ | 244 53.5% YoY 101.7% QoQ | 232 90.2% YoY -4.9% QoQ | 415 501.4% YoY 78.9% QoQ |
| 2024 | 44 -63.6% YoY -89.4% QoQ | - | - | - |
The average 5 years interest of Aldeyra Therapeutics was 13.94 per week. The last year interest of Aldeyra Therapeutics compared to the last 5 years has changed by 38.24%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 25.54%.
After 39 days of this quarter the interest is at 67.0. Based on that we can calculate that during remaining 52 days it will total up to 156.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 70 | 267 281.4% QoQ | 83 -68.9% QoQ | 271 226.5% QoQ |
| 2020 | 87 24.3% YoY -67.9% QoQ | 73 -72.7% YoY -16.1% QoQ | 89 7.2% YoY 21.9% QoQ | 89 -67.2% YoY 0.0% QoQ |
| 2021 | 177 103.4% YoY 98.9% QoQ | 127 74.0% YoY -28.2% QoQ | 82 -7.9% YoY -35.4% QoQ | 134 50.6% YoY 63.4% QoQ |
| 2022 | 218 23.2% YoY 62.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 79 -3.7% YoY inf% QoQ | 57 -57.5% YoY -27.8% QoQ |
| 2023 | 199 -8.7% YoY 249.1% QoQ | 170 inf% YoY -14.6% QoQ | 78 -1.3% YoY -54.1% QoQ | 186 226.3% YoY 138.5% QoQ |
| 2024 | 67 -66.3% YoY -64.0% QoQ | - | - | - |
The average 5 years interest of Reproxalap was 9.97 per week. The last year interest of Reproxalap compared to the last 5 years has changed by 26.18%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -10.14%.
There is not enough data for Dry eye diseases treatment to provide analysis
There is not enough data for Dry eye diseases treatment to provide correlation calculation
There is not enough data for Dry eye diseases treatment to provide analysis
After 39 days of this quarter the interest is at 22.0. Based on that we can calculate that during remaining 52 days it will total up to 51.0. COVID-19 treatment expected interest is significantly lower compared to same quarter last year (-48.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 3 | 8 166.7% QoQ | 3 -62.5% QoQ | 3 0.0% QoQ |
| 2020 | 355 11733.3% YoY 11733.3% QoQ | 594 7325.0% YoY 67.3% QoQ | 467 15466.7% YoY -21.4% QoQ | 343 11333.3% YoY -26.6% QoQ |
| 2021 | 287 -19.2% YoY -16.3% QoQ | 196 -67.0% YoY -31.7% QoQ | 409 -12.4% YoY 108.7% QoQ | 307 -10.5% YoY -24.9% QoQ |
| 2022 | 259 -9.8% YoY -15.6% QoQ | 174 -11.2% YoY -32.8% QoQ | 170 -58.4% YoY -2.3% QoQ | 118 -61.6% YoY -30.6% QoQ |
| 2023 | 99 -61.8% YoY -16.1% QoQ | 61 -64.9% YoY -38.4% QoQ | 53 -68.8% YoY -13.1% QoQ | 69 -41.5% YoY 30.2% QoQ |
| 2024 | 22 -77.8% YoY -68.1% QoQ | - | - | - |
The average 5 years interest of COVID-19 treatment was 15.33 per week. The last year interest of COVID-19 treatment compared to the last 5 years has changed by -68.49%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1205.41%.
There is not enough data for Atopic asthma treatment to provide analysis
There is not enough data for Atopic asthma treatment to provide correlation calculation
There is not enough data for Atopic asthma treatment to provide analysis
After 39 days of this quarter the interest is at 419.0. Based on that we can calculate that during remaining 52 days it will total up to 978.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 476 | 731 53.6% QoQ | 740 1.2% QoQ | 807 9.1% QoQ |
| 2020 | 731 53.6% YoY -9.4% QoQ | 795 8.8% YoY 8.8% QoQ | 724 -2.2% YoY -8.9% QoQ | 892 10.5% YoY 23.2% QoQ |
| 2021 | 982 34.3% YoY 10.1% QoQ | 1031 29.7% YoY 5.0% QoQ | 983 35.8% YoY -4.7% QoQ | 950 6.5% YoY -3.4% QoQ |
| 2022 | 1101 12.1% YoY 15.9% QoQ | 1018 -1.3% YoY -7.5% QoQ | 1013 3.1% YoY -0.5% QoQ | 1025 7.9% YoY 1.2% QoQ |
| 2023 | 1119 1.6% YoY 9.2% QoQ | 1052 3.3% YoY -6.0% QoQ | 1010 -0.3% YoY -4.0% QoQ | 1193 16.4% YoY 18.1% QoQ |
| 2024 | 419 -62.6% YoY -64.9% QoQ | - | - | - |
The average 5 years interest of Psoriasis treatment was 72.0 per week. The last year interest of Psoriasis treatment compared to the last 5 years has changed by 14.26%. The interest for Psoriasis treatment is relatively stable in the last 5 years. The last year interest is quite higher compared to 5 years ago. It has increased by 39.68%.
After 39 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 52 days it will total up to 33.0. Alcohol intoxication treatment expected interest is significantly lower compared to previous quarter (-74.2%) and same quarter last year (-76.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 45 | 50 11.1% QoQ | 117 134.0% QoQ | 82 -29.9% QoQ |
| 2020 | 72 60.0% YoY -12.2% QoQ | 71 42.0% YoY -1.4% QoQ | 11 -90.6% YoY -84.5% QoQ | 137 67.1% YoY 1145.5% QoQ |
| 2021 | 107 48.6% YoY -21.9% QoQ | 81 14.1% YoY -24.3% QoQ | 150 1263.6% YoY 85.2% QoQ | 138 0.7% YoY -8.0% QoQ |
| 2022 | 161 50.5% YoY 16.7% QoQ | 106 30.9% YoY -34.2% QoQ | 160 6.7% YoY 50.9% QoQ | 152 10.1% YoY -5.0% QoQ |
| 2023 | 141 -12.4% YoY -7.2% QoQ | 117 10.4% YoY -17.0% QoQ | 56 -65.0% YoY -52.1% QoQ | 128 -15.8% YoY 128.6% QoQ |
| 2024 | 14 -90.1% YoY -89.1% QoQ | - | - | - |
The average 5 years interest of Alcohol intoxication treatment was 8.03 per week. The last year interest of Alcohol intoxication treatment compared to the last 5 years has changed by -9.22%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 19.9%.
Google Trends for Vitreoretinal lymphoma cancer treatment
Not enough data for reliable calculations!
There is not enough data for Vitreoretinal lymphoma cancer treatment to provide analysis
There is not enough data for Vitreoretinal lymphoma cancer treatment to provide correlation calculation
There is not enough data for Vitreoretinal lymphoma cancer treatment to provide analysis
After 39 days of this quarter the interest is at 108.0. Based on that we can calculate that during remaining 52 days it will total up to 252.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 126 | 146 15.9% QoQ | 169 15.8% QoQ | 141 -16.6% QoQ |
| 2020 | 347 175.4% YoY 146.1% QoQ | 217 48.6% YoY -37.5% QoQ | 262 55.0% YoY 20.7% QoQ | 221 56.7% YoY -15.6% QoQ |
| 2021 | 304 -12.4% YoY 37.6% QoQ | 339 56.2% YoY 11.5% QoQ | 131 -50.0% YoY -61.4% QoQ | 306 38.5% YoY 133.6% QoQ |
| 2022 | 424 39.5% YoY 38.6% QoQ | 285 -15.9% YoY -32.8% QoQ | 290 121.4% YoY 1.8% QoQ | 232 -24.2% YoY -20.0% QoQ |
| 2023 | 320 -24.5% YoY 37.9% QoQ | 483 69.5% YoY 50.9% QoQ | 244 -15.9% YoY -49.5% QoQ | 292 25.9% YoY 19.7% QoQ |
| 2024 | 108 -66.2% YoY -63.0% QoQ | - | - | - |
The average 5 years interest of Retinitis pigmentosa treatment was 20.64 per week. The last year interest of Retinitis pigmentosa treatment compared to the last 5 years has changed by 20.74%. The interest for Retinitis pigmentosa treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 59.03%.
After 39 days of this quarter the interest is at 100.0. Based on that we can calculate that during remaining 52 days it will total up to 233.0. Geographic atrophy treatment expected interest is significantly higher compared to previous quarter (+441.9%) and same quarter last year (+565.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 44 | 24 -45.5% QoQ | 10 -58.3% QoQ | 63 530.0% QoQ |
| 2020 | 41 -6.8% YoY -34.9% QoQ | 17 -29.2% YoY -58.5% QoQ | 29 190.0% YoY 70.6% QoQ | 27 -57.1% YoY -6.9% QoQ |
| 2021 | 8 -80.5% YoY -70.4% QoQ | 11 -35.3% YoY 37.5% QoQ | 57 96.6% YoY 418.2% QoQ | 82 203.7% YoY 43.9% QoQ |
| 2022 | 46 475.0% YoY -43.9% QoQ | 56 409.1% YoY 21.7% QoQ | 21 -63.2% YoY -62.5% QoQ | 21 -74.4% YoY 0.0% QoQ |
| 2023 | 35 -23.9% YoY 66.7% QoQ | 110 96.4% YoY 214.3% QoQ | 43 104.8% YoY -60.9% QoQ | 43 104.8% YoY 0.0% QoQ |
| 2024 | 100 185.7% YoY 132.6% QoQ | - | - | - |
The average 5 years interest of Geographic atrophy treatment was 3.4 per week. The last year interest of Geographic atrophy treatment compared to the last 5 years has changed by 84.41%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 113.27%.
There is not enough data for Aldeyra Therapeutics drug pipeline to provide analysis
There is not enough data for Aldeyra Therapeutics drug pipeline to provide correlation calculation
There is not enough data for Aldeyra Therapeutics drug pipeline to provide analysis
There is not enough data for Biotechnology stocks to watch to provide analysis
There is not enough data for Biotechnology stocks to watch to provide correlation calculation
There is not enough data for Biotechnology stocks to watch to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Aldeyra Therapeutics -stock -company expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 58 | 92 58.6% QoQ | 39 -57.6% QoQ | 31 -20.5% QoQ |
| 2020 | 96 65.5% YoY 209.7% QoQ | 165 79.3% YoY 71.9% QoQ | 86 120.5% YoY -47.9% QoQ | 103 232.3% YoY 19.8% QoQ |
| 2021 | 239 149.0% YoY 132.0% QoQ | 124 -24.8% YoY -48.1% QoQ | 89 3.5% YoY -28.2% QoQ | 85 -17.5% YoY -4.5% QoQ |
| 2022 | 92 -61.5% YoY 8.2% QoQ | 102 -17.7% YoY 10.9% QoQ | 151 69.7% YoY 48.0% QoQ | 78 -8.2% YoY -48.3% QoQ |
| 2023 | 68 -26.1% YoY -12.8% QoQ | 112 9.8% YoY 64.7% QoQ | 110 -27.2% YoY -1.8% QoQ | 72 -7.7% YoY -34.5% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Aldeyra Therapeutics -stock -company was 7.63 per week. The last year interest of Aldeyra Therapeutics -stock -company compared to the last 5 years has changed by -16.38%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 37.8%.